Vertex Pharmaceuticals's total assets for Q2 2026 were $27.42B, an increase of 3.55% from the previous quarter. MX:VRTX total liabilities were $7.18B for the fiscal quarter, a 0.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.